Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

215
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
215
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

523
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
523
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

430
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
430
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

931
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
931

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Grower or Shower: Is It Even a Thing? Penile Growth Patterns and Erectile Dysfunction Aetiology in Growers and Showers.

Andrology·2026
Same author

Predictors of penile prosthesis length: results from the PHOENIX registry.

International journal of impotence research·2026
Same author

Impact of PA-100 AST System Rapid Antibiotic Susceptibility Test on Antibiotic Prescription for Community-Acquired Urinary Tract Infections in Spanish Primary Care Settings.

Antibiotics (Basel, Switzerland)·2026
Same author

Development and validation of PEYRO-Q: a novel multidimensional patient-reported outcome measure for Peyronie's disease.

Sexual medicine·2026
Same author

Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

Diagnostics (Basel, Switzerland)·2026
Same author

Peyronie's disease in Spain: a prospective study.

Sexual medicine·2026

Related Experiment Video

Updated: Jan 6, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.3K

Plication techniques in Peyronie's disease: new developments.

Borja García-Gómez1,2, Daniel Antonio González-Padilla1, Manuel Alonso-Isa1

  • 1Hospital Universitario 12 Octubre. Grupo de Investigación Salud Integral del Varón i+D+I, Madrid, Spain.

International Journal of Impotence Research
|October 5, 2019
PubMed
Summary
This summary is machine-generated.

Penile plication (PP) is a surgical option for Peyronie's disease (PD) with recent advancements improving outcomes. New techniques expand indications and minimize complications for men with penile curvature.

More Related Videos

Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
03:55

Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis

Published on: October 18, 2024

660
Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
03:37

Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats

Published on: October 11, 2024

675

Related Experiment Videos

Last Updated: Jan 6, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.3K
Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
03:55

Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis

Published on: October 18, 2024

660
Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
03:37

Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats

Published on: October 11, 2024

675

Area of Science:

  • Urology
  • Andrology
  • Surgical Innovation

Background:

  • Surgical correction is the gold standard for stable Peyronie's disease (PD).
  • Penile plication (PP) is suitable for specific PD patients with adequate erectile function and penile length.
  • Established criteria for PP include curvature <60° and predicted shortening <20%.

Purpose of the Study:

  • To review recent advancements in penile plication (PP) for Peyronie's disease (PD).
  • To explore new developments in PP techniques and indications over the last decade.

Main Methods:

  • A nonsystematic literature review was conducted.
  • Searches were performed in PubMed and EMBASE databases (Jan 2009 - Apr 2019).
  • Keywords included 'Peyronie', 'penile curvature', 'penile induration', 'plication', and 'plicature'.

Main Results:

  • New developments include penoscrotal incisions to avoid degloving.
  • A mathematical model for predicting length loss post-PP has been developed.
  • Indications have widened to include severe (≥60°) or complex curvatures.
  • Techniques like burying knots and plaque modification (thinning/incising) address complications.

Conclusions:

  • Penile plication (PP) is a reliable procedure with excellent outcomes in well-selected patients.
  • Recent innovations enhance PP's applicability and safety for Peyronie's disease.
  • Further prospective randomized trials are needed to compare PP techniques.